Edwards Lifesciences (EW) stock is in focus as the company hikes 2026 outlook as it drops $945M JenaValve buyout deal after FTC court win. Read more here.
Edwards drops JenaValve bid as court blocks the deal (EW:NYSE)
Edwards Lifesciences (EW) stock is in focus as the company hikes 2026 outlook as it drops $945M JenaValve buyout deal after FTC court win. Read more here.
